Mark Dipaolo
Chairman chez INNOVIVA, INC.
Fortune : 2 M $ au 31/03/2024
Profil
Mark A.
Dipaolo is currently the Chairman at Innoviva, Inc., an Independent Director at Amarin Corp.
Plc, and a Senior Managing Director at Sarissa Capital Acquisition Corp.
Previously, he served as an Independent Director at Novelion Therapeutics, Inc. and worked as an Attorney at Willkie Farr & Gallagher LLP.
Mr. Dipaolo obtained his undergraduate degree from Fordham University and his graduate degree from Georgetown University Law Center.
Détentions connues dans des sociétés publiques
| Société | Date | Nombre d'actions | Valorisation | Date de valorisation |
|---|---|---|---|---|
INNOVIVA, INC.
0,17% | 22/05/2023 | 104 706 ( 0,17% ) | 2 M $ | 31/03/2024 |
AMARIN CORPORATION
-.--% | 18/04/2024 | 0 ( -.--% ) | - $ | 31/03/2024 |
Postes actifs de Mark Dipaolo
| Sociétés | Poste | Début |
|---|---|---|
| INNOVIVA, INC. | Chairman | 22/05/2023 |
| SARISSA CAPITAL ACQUISITION CORP. | Corporate Officer/Principal | 20/10/2020 |
| AMARIN CORPORATION PLC | Director/Board Member | 28/02/2023 |
Anciens postes connus de Mark Dipaolo
| Sociétés | Poste | Fin |
|---|---|---|
| NOVELION THERAPEUTICS INC. | Director/Board Member | 13/09/2018 |
Willkie Farr & Gallagher LLP
 Willkie Farr & Gallagher LLP Miscellaneous Commercial ServicesCommercial Services Willkie Farr & Gallagher LLP engages in the provision of legal services. It specializes in antitrust and competition, asset management, business reorganization and restructuring, communications and media, corporate and financial services, cybersecurity and privacy, energy, and executive compensation and employee benefits practice areas. The company was founded in 1888 and is headquartered in New York, NY. | Corporate Officer/Principal | 01/09/2018 |
Formation de Mark Dipaolo
| Fordham University | Undergraduate Degree |
| Georgetown University Law Center | Graduate Degree |
Expériences
Fonctions occupées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Sociétés cotées | 2 |
|---|---|
| AMARIN CORPORATION PLC | Health Technology |
| INNOVIVA, INC. | Health Technology |
| Entreprise privées | 3 |
|---|---|
Willkie Farr & Gallagher LLP
Willkie Farr & Gallagher LLP Miscellaneous Commercial ServicesCommercial Services Willkie Farr & Gallagher LLP engages in the provision of legal services. It specializes in antitrust and competition, asset management, business reorganization and restructuring, communications and media, corporate and financial services, cybersecurity and privacy, energy, and executive compensation and employee benefits practice areas. The company was founded in 1888 and is headquartered in New York, NY. | Commercial Services |
Novelion Therapeutics, Inc.
 Novelion Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Novelion Therapeutics, Inc. engaged in the development and commercialization of pharmaceuitical products. It focused in providing new standards of care for individuals living with rare diseases. The company was founded on February 3, 1981 and was headquartered in Vancouver, Canada. | Health Technology |
Sarissa Capital Acquisition Corp.
 Sarissa Capital Acquisition Corp. Financial ConglomeratesFinance Sarissa Capital Acquisition Corp. operates as a blank check company. It was formed for the purpose of effecting a merger, share exchange, asset acquisition, share purchase, and reorganization or similar business combination with one or more businesses. The company was founded on August 12, 2020 and is headquartered in Greenwich, CT. | Finance |
